What GLP-1 penetration actually tells you
The headline number is striking. GLP-1 drugs for weight loss and diabetes management now reach an estimated 23 percent of US households, per Circana data cited in prior coverage, with Circana projecting penetration climbing to 35 percent by 2030, per Food Dive reporting. But the adherence data complicates that picture in a way that matters for how you plan your portfolio.
Six percent of US adults are currently taking GLP-1 drugs, according to Kaiser research cited at a Food Business News webinar on May 5, 2026. At the same time, 35 percent of Americans say they want to try the drugs in the future, according to PwC data cited at the same event. The gap between intent and action is large, and the dropout rate explains why headline penetration numbers have not translated into a permanent new consumer segment. Approximately 75 percent of GLP-1 users discontinue within two years, according to University of Pennsylvania research cited by Culinary Tides president Suzy Badaracco, and dropout rates within the first year alone exceed 50 percent. Badaracco described the active user base as "a revolving 6 percent" at the webinar.
What this means for brand planning is precise. You cannot build a permanent product line around a static group of GLP-1 users, because that group churns. What you can build around is the broader dietary shift the drugs have normalised: smaller portions, more protein per calorie, more fibre, and simpler ingredient lists. Those preferences are moving well beyond active users into the general shopper population.
Where protein demand is showing up in new products
The clearest commercial signal of health as a shopper default is the pace of protein innovation across categories that were never associated with functional nutrition.
Jeff Church, who built Suja Juice into a brand topping $100 million in sales, launched Proda, a protein soda with 10 grams of whey protein isolate per can and zero sugar, at Sprouts Farmers Market and on Amazon in 2026. His thesis rests on a consumer overlap: 60 percent of adult consumers take a protein supplement, and 50 percent of adults drink soda. Proda enters alongside competing entrants including SkyPop, Koia, and Clear Protein Soda from Clean Simple Eats, signalling that protein soda is now a category, not a single brand bet.
Hain Celestial is moving in the same direction at a portfolio level. CEO Alison Lewis said on May 11, 2026 that the company is rolling out protein-heavy products across multiple brands. The Greek Gods yogurt brand launched a high-protein variant in April 2026, and Earth's Best, Hain's baby-and-toddler brand, is entering what it calls a "high-density nutrition" segment for older children with a new finger food product containing protein and fibre. That is a meaningful signal: protein is no longer just a gym-and-sports-nutrition story. It is landing in the baby aisle, the yogurt set, and the carbonated drinks fixture at the same time.
On the ingredient supply side, Italian poultry group Amadori acquired the Unconventional plant-based foods business from Granarolo in 2026, framing itself as "The Italian Protein Company" and setting a goal to become one of the top three branded players in plant-based processed foods in Italy. Amadori's move shows that protein as a brand positioning is pulling in companies that would not historically have called themselves wellness brands.
How older shoppers are expanding the healthy-ageing market
The health-as-default story is not just about GLP-1 users or younger functional-nutrition shoppers. Older consumers are pulling the category into the mainstream in a structural way. The global elderly nutrition market is projected to reach $43.1 billion by 2032, according to data cited in a FoodNavigator analysis. Protein sits at the top of the priority list for this cohort because older adults lose muscle mass and the capacity to absorb nutrients as they age, requiring higher intake than younger people to maintain health and independence.
This is a fast-growing shopper segment that arrives at the shelf with specific, non-negotiable nutrient requirements: protein, B12, calcium, and omega-3 fatty acids. They are not browsing. They are looking for products that do a job. If your pack does not communicate the nutrient content clearly and the portion size is wrong for a smaller appetite, you will lose the sale regardless of brand strength.
What the pack architecture question looks like right now
Single-portion pack shifts are accelerating, driven by two forces that happen to be reinforcing each other. GLP-1 users eat less per sitting and want portion control built into the pack. Older shoppers with smaller appetites want the same thing. Households are also getting smaller on average, reducing the case for the large family format in many categories.
The commercial tension is real. Smaller packs typically carry a higher price per unit, which creates friction with the broad group of shoppers under cost-of-living pressure. McKinsey analysis shows volume growth for food and beverage CPG now sits below 1 percent annually, and total shareholder return for major global CPG players is down about 7 percent since 2023 while the S&P 500 is up 9 percent. Brands that add a health-and-wellness premium to a smaller pack without explaining the value will face resistance from a shopper who is already trading down in other parts of the basket.
The packaging message has to carry the weight. If a smaller single-serve format costs more per gram, the label needs to communicate why: more protein per serving, cleaner ingredients, a specific health benefit tied to a nutrient the shopper already cares about. Shoppers who arrive with health as their filter are willing to pay more. But they need the justification on the front of pack, not buried in fine print on the back.
What to watch next
Three signals are worth tracking closely over the next quarter.
First, GLP-1 adherence data. If dropout rates stay above 50 percent in year one, the active user base will remain a revolving segment rather than a compounding one. That keeps the biggest commercial opportunity in the broader shopper population that has adopted GLP-1-adjacent preferences without taking the drugs. Watch for updated Circana and Kaiser tracking on active users.
Second, retailer responses in the protein fixture. Sprouts is already carrying Proda at launch. If the major conventional grocers begin dedicating shelf space to protein-functional carbonated drinks alongside traditional sports nutrition, that signals the category has crossed from specialty to mainstream. Watch planogram resets at Kroger, Albertsons, and Walmart in Q3.
Third, how Big CPG responds at a portfolio level. Hain Celestial is the clearest current example of a named brand systematically moving toward protein across multiple categories at once. McKinsey's analysis of CPG underperformance makes clear that standing still on portfolio transformation carries a rising cost. The brands that move on protein, fibre, and portion architecture before the next planogram reset will be better placed than those still waiting to see if the trend holds.